Open AccessIn Reply
Author(s) -
Xu Binghe,
Seidman Andrew,
Chan Stephen
Publication year - 2015
Publication title -
the oncologist
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.176
H-Index - 164
eISSN - 1549-490X
pISSN - 1083-7159
DOI - 10.1634/theoncologist.2014-0284
Subject(s) - medicine , adjuvant , oncology , adjuvant therapy , breast cancer , overall survival , cancer , intensive care medicine
Many factors contribute to patient survival in metastatic breast cancer and other late‐stage cancers. It is doubtful that adjuvant therapy causes a worse survival outcome. This being said, should resistance develop following adjuvant therapy, the patient needs to be offered a first‐line solution that is free of cross‐resistance.